Vida Ventures GP III, L.L.C. 13D and 13G filings for Vigil Neuroscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-12 5:33 pm Sale | 2025-06-10 | 13D | Vigil Neuroscience, Inc. VIGL | Vida Ventures GP III, L.L.C. | 1,634,798 3.500% | -1,207,202 (-42.48%) | Filing |
| 2025-06-09 5:48 pm Sale | 2025-06-05 | 13D | Vigil Neuroscience, Inc. VIGL | Vida Ventures GP III, L.L.C. | 2,842,000 6.100% | -2,200,012 (-43.63%) | Filing |
| 2024-10-09 6:22 pm Purchase | 2024-08-13 | 13D | Vigil Neuroscience, Inc. VIGL | Vida Ventures GP III, L.L.C. | 5,042,012 12.700% | 26,083 (+0.52%) | Filing |
| 2023-02-10 4:31 pm Purchase | 2022-01-11 | 13D | Vigil Neuroscience, Inc. VIGL | Vida Ventures GP III, L.L.C. | 5,015,929 14.100% | 5,015,929 (New Position) | Filing |